T-Cell Immunotherapy Market - Global Outlook and Forecast 2022-2028

[vidhya]

Bharat Book Bureau Provides the Trending Industry Research Report on“T-Cell Immunotherapy Market - Global Outlook and Forecast 2022-2028”under Life Sciences Market Research Report. The report offers a collection of superior Market research, Market analysis, competitive intelligence and Market reports.

Executive Summary

This report contains market size and forecasts of T-Cell Immunotherapy in Global, including the following market information:

Global T-Cell Immunotherapy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)
The global T-Cell Immunotherapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
CAR-T Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of T-Cell Immunotherapy include Adaptimmune, Altor Bioscience Corporation, Cellectis, Juno Therapeutics, Kite Pharma, Novartis, Takara Bio and Unum Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the T-Cell Immunotherapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global T-Cell Immunotherapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global T-Cell Immunotherapy Market Segment Percentages, by Type, 2021 (%)
CAR-T
TCR
TIL Therapies
Global T-Cell Immunotherapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global T-Cell Immunotherapy Market Segment Percentages, by Application, 2021 (%)
Stomach Cancer
Lung Cancer
Colorectal Cancer
Esophagus Cancer
Pancreatic Cancer
Others
Global T-Cell Immunotherapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global T-Cell Immunotherapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies T-Cell Immunotherapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies T-Cell Immunotherapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Adaptimmune
Altor Bioscience Corporation
Cellectis
Juno Therapeutics
Kite Pharma
Novartis
Takara Bio
Unum Therapeutics

Browse our full report with Table of Content : https://www.bharatbook.com/report/1329914/t-cell-immunotherapy-mark...

About Bharat Book Bureau:
Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 15,00,000 reports and insights that includes latest Industry Study, Industry Trends & Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.

Contact us at:
Bharat Book Bureau
Tel: [phone]
Email: [e-mail]
Website: www.bharatbook.com